In a promising development, U.S. life expectancy surged in 2023, reaching its highest point since the start of the COVID-19 pandemic, according to the latest report from the Centers for Disease Control and Prevention (CDC). The new figures show that life expectancy at birth increased to 78.4 years, a rise of nearly one full year from 2022’s figure of 77.5 years.
This increase is particularly remarkable, as life expectancy in the U.S. had historically experienced only minor fluctuations. Ken Kochanek, a statistician with the CDC's National Center for Health Statistics, noted that such a sharp rise in life expectancy had not been observed prior to the pandemic. “Before the pandemic, life expectancy would typically move by only a tenth or two,” Kochanek remarked. “However, after the sharp decline during the pandemic, we now see an equally significant rebound."
Between 2019 and 2021, U.S. life expectancy saw a steep decline, dropping from 78.8 years to 76.4 years. This drop was primarily attributed to the devastating impacts of COVID-19, which led to a high number of deaths and widespread disruption. However, as COVID-19 cases and deaths decreased substantially in 2023, life expectancy began to recover.
COVID-19 was the fourth leading cause of death in 2022 but fell to the 10th position in 2023, reflecting the significant decline in its mortality rate. The number of deaths directly attributed to COVID-19 dropped by more than 80%, from over 350,000 deaths in 2020 to just over 76,000 in 2023. These findings were based on an analysis of death certificates from all U.S. states and Washington, D.C., providing a comprehensive look at national mortality trends.
While the decline in COVID-19 deaths is encouraging, experts emphasize that the virus is not completely gone. Kochanek cautioned that while the number of deaths has dropped dramatically, it’s still too early to predict if this decline will continue at the same rate or stabilize at a more predictable level. "COVID is not going to disappear entirely,” he explained, acknowledging that there could still be future spikes.
Despite this, the overall death rate in the U.S. saw a 6% reduction in 2023, driven by a decrease in fatalities from many leading causes of death.
The five leading causes of death in the U.S. last year were heart disease, cancer, unintentional injuries, stroke, and chronic lower respiratory diseases. The new data revealed a positive trend, with death rates falling for nine out of the top 10 causes of death in 2023. However, cancer-related deaths showed little change compared to previous years.
The category of "unintentional injuries" includes drug overdoses, which have long been a significant issue in the U.S. However, a CDC report released alongside the life expectancy data highlighted a positive shift: drug overdose deaths decreased for the first time since 2018. The rate of overdose deaths in 2023 was approximately 31.3 per 100,000 people, compared to 32.6 in 2022. The most significant decrease was observed in the 15 to 24 age group, where overdose deaths dropped by more than 10%.
Opioid-related overdose deaths, which had surged in previous years, also showed a significant reduction in 2023, with a 17% decrease in deaths linked to opioid drugs such as morphine, oxycodone, and hydrocodone. However, the picture remains mixed, as overdose deaths involving drugs like cocaine and methamphetamine showed slight increases.
This mixed trend indicates that while progress has been made in reducing overdose deaths, further work is needed to address other substances that continue to contribute to rising mortality rates in certain groups.
The report also delved into mortality rates by race, ethnicity, and gender, highlighting the disparities in how different groups have experienced changes in life expectancy. Overall, minority racial and ethnic groups, including Black, Asian, and Hispanic populations, saw larger reductions in death rates compared to white individuals. This was partly due to the higher mortality rates these groups experienced during the peak of the pandemic.
The most significant improvements in death rates were observed among Hispanic individuals, with decreases of 10.5% for men and 8% for women. American Indian and Alaska Native populations also saw substantial reductions, with male death rates dropping by 13.5% and female death rates falling by 11.5%.
Kochanek noted that the higher mortality rates in these groups in previous years left more room for improvement. “These groups started at a higher plateau during the pandemic, so they had more room to drop,” he explained.
Despite the encouraging trend of rising life expectancy, experts caution that ongoing efforts are necessary to sustain this progress. As Kochanek remarked, “We can only hope that it continues.” Continued improvements in healthcare, public health initiatives, and a stronger focus on addressing health disparities will be key to ensuring that the progress seen in 2023 is not only maintained but furthered in the years to come.
While the decrease in COVID-19 deaths and the overall improvement in life expectancy are promising, the path to health equity and long-term population health remains complex. A more concerted effort to address the root causes of mortality, including lifestyle-related diseases, injuries, and substance abuse, will be essential for driving sustainable improvements in public health.
As the U.S. continues to recover from the impacts of the pandemic, the focus must shift toward preventing future health crises and ensuring that the gains in life expectancy are not fleeting. The year 2023 marked a turning point, but the work to create a healthier, longer-living society is far from over.